RFK Jr. fires top aides in HHS shakeup
FacebookTweetLink
US Health and Human Services Secretary Robert F. Kennedy Jr. has fired two of his top aides in an abrupt shakeup of the leadership at the nation's sprawling health department, two people familiar with the matter told CNN.
Kennedy this week ousted chief of staff Heather Flick Melanson and deputy chief of staff for policy Hannah Anderson, dismissing them after only a handful of months on the job.
The decision came after Kennedy lost confidence in them as part of his leadership team, one of the people familiar with the matter said, although it was unclear whether there was a single triggering event that prompted the firings.
In a statement, an HHS spokesman confirmed the moves and said the department's White House liaison, Matt Buckham, would serve as acting chief of staff.
'He brings valuable experience in personnel strategy and organizational management to this new role,' the spokesman said. 'Secretary Kennedy thanks the outgoing leadership for their service and looks forward to working closely with Mr. Buckham as the Department continues advancing its mission to Make America Healthy Again.'
Kennedy has not yet decided on permanent replacements for Flick and Anderson, the people familiar said.
The move leaves Kennedy needing to fill key senior positions at HHS just months into his tenure, and at a moment when the department has come under growing scrutiny over its efforts to overhaul the nation's vaccine policies and advance a range of major health and food priorities.
Flick was among Kennedy's most experienced Washington hands, having served at HHS during President Donald Trump's first term, first as its acting general counsel and then as acting secretary for administration and a senior adviser to then-HHS Secretary Alex Azar.
Anderson joined HHS after stints on Capitol Hill as a GOP staffer, including as health policy adviser to Republicans on the Senate's main health committee. She had most recently headed up health care issues at the Trump-aligned America First Policy Institute think tank.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
10 minutes ago
- Newsweek
Donald Trump Doubles Down on Mathematically Impossible Drug Price Cuts
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. President Donald Trump has doubled down on his claim of reducing drug prices by amounts that are mathematically impossible. Trump told reporters on Sunday that his administration had cut the price of some prescription drugs by as much as 1,500 percent. "Well, one of the things they're going to be talking about pretty soon are the tremendous drop in drug prices. You know, we've cut drug prices by 1,200, 1,300, 1,400, 1,500 percent. I don't mean 50 percent. I mean 14-, 1,500 percent," the president said. When asked to clarify the president's remarks, White House spokesperson Kush Desai told Newsweek, "It's an objective fact that Americans are paying exponentially more for the same exact drugs as people in other developed countries pay, and it's an objective fact that no other Administration has done more to rectify this unfair burden for the American people." Why It Matters Trump's remarks signal a misunderstanding of how pricing and percentages work, which could undermine public confidence in his ability to tackle problems such as drug pricing. President Donald Trump speaks with reporters near Air Force One at the Lehigh Valley International Airport in Allentown, Pennsylvania, on August 3. President Donald Trump speaks with reporters near Air Force One at the Lehigh Valley International Airport in Allentown, Pennsylvania, on August To Know Reducing the price of a drug by 100 percent would make it free, and a reduction greater than 100 percent suggests pharmaceutical companies would pay their customers to take their prescription drugs. Commenting on Trump's claims, Jeffrey Frankel, a professor of capital formation and growth at Harvard University, told Newsweek that the numbers were "indeed mathematically impossible." On Friday, the president made similar claims of bringing drug prices down by "1,000 percent, 1,200 percent" in an interview with Newsmax's Rob Finnerty. That came a day after the White House said Trump had written to the heads of 17 pharmaceutical companies outlining steps they needed to take to bring down the prices of drugs sold in the U.S. to match the lowest price paid by a group of other economically advanced countries. According to a fact sheet the White House released on Thursday, Trump's letters said the pharmaceutical manufacturers' proposals for implementing his May executive order—which seeks to achieve "most favored nation" pricing in the United States—had "fallen short." However, it did not mention the percentage reductions the president has discussed in recent days. What People Are Saying Jeffrey Frankel, a professor of capital formation and growth at Harvard University, told Newsweek: "They are indeed mathematically impossible. If he cut prices 90 percent, the drugs would cost 1/10 as much as before. If 100 percent, then they would cost zero. If cutting 1,000 percent means a thing, then it means that the drug company pays you (a lot) to take the drug." He added: "It's almost as if Trump is making fun of his supporters, seeing what increasingly absurd statements he can get away with." Justin Wolfers, a professor of economics and public policy at the University of Michigan, told Newsweek: "This is not a question for an economist, but rather a sixth grader. After all, the Common Core curriculum standard states that students should know how to 'find a percent of a quantity as a rate per 100 (e.g., 30 percent of a quantity means 30/100 times the quantity).'" Wolfers added: "I just checked with my sixth grader (Oliver Wolfers), and he confirmed that he has studied percentages and that the president's math does not make sense 'because then the prices would be negative.' He added, 'Is he an idiot?' before returning to watching YouTube. Oliver's father agrees with Oliver's mathematical analysis and encourages him to use more positive language when engaging with fellow kids." Pau Pujolas, a professor of economics at McMaster University, told Newsweek: "If your grocery bill is $100 and you get a 50 percent reduction in price, you pay $50. If you get a 75 percent reduction, you pay $25. If you get a 99 percent reduction, you pay $1. If you get a 100 percent reduction, you pay $0. You can't get a reduction larger than that ... so 1,200 percent doesn't make sense. "Talking about bad math: Firing Erika McEntarfer, the director of the Bureau of Labor Statistics (BLS), is way worse than a POTUS not knowing how to operate with basic percentages. Let's not miss the forest for the trees." President Donald Trump said at a Republican dinner in July: "This is something that nobody else can do. We're gonna get the drug prices down—not 30 or 40 percent, which would be great, not 50 or 60 percent. No, we're gonna get them down 1,000 percent, 600 percent, 500 percent, 1,500 percent. Numbers that are not even thought to be achievable." The White House fact sheet said: "From this point forward, President Trump will only accept from drug manufacturers a commitment that provides American families immediate relief from vastly inflated drug prices and an end to the freeriding by European and other developed nations on American innovations." Journalist James Surowiecki wrote on X in response to Trump's comments on Sunday: "It's not just that the math here is nonsensical. It's that Trump hasn't actually cut drug prices yet at all. He's literally just sent letters to drugmakers telling them to cut prices. Does he know that and is lying? Or is he deluded? We have no idea." What Happens Next Trump and the White House have not clarified what he means when he says drug prices will come down by as much as 1,500 percent. The president's letters to pharmaceutical companies give them a 60-day window to present a viable plan to reduce U.S. drug prices.
Forbes
40 minutes ago
- Forbes
Obamacare Premiums Are Climbing Again. But Americans Finally Have An Alternative.
Get ready to pay more for insurance coverage through Obamacare's exchanges. The median premium increase for plans from 105 insurers in 19 states and the District of Columbia will be 15% in 2026, according to the Kaiser Family Foundation. That's more than double the median premium increase of 7% this year. Obamacare premiums rise every year. But there are two things that make this year's premium hikes different. The first is that the enhanced premium tax credits instituted under President Biden are expiring at the end of this year. These COVID-era subsidies capped premiums for all Americans covered on the exchanges at 8.5% of income, with the federal government picking up the rest. People with incomes below four times the poverty level—$128,600 for a family of four—were responsible for even less of their premiums, and the percentage they were obligated to pay declined with income. The second is that a lot more Americans will be eligible for tax-advantaged health savings accounts next year. Republicans' One Big Beautiful Bill Act made all bronze and catastrophic Obamacare plans HSA-compatible. In the long term, increased adoption of HSAs could lead to lower health costs—and lower insurance premiums. Let's take stock of how Obamacare's been doing. In 2013, the year before the law took effect, the average monthly individual market premium was $244. This year, it was $590. According to the Paragon Health Institute, the cost of exchange coverage rose 50% faster than the cost of employer-sponsored coverage between 2014 and 2023. Federal subsidies have obscured these surging premiums at immense cost to taxpayers. Extending Biden's enhanced subsidies permanently would cost $335 billion through 2034. The fact that it takes billions of taxpayer dollars to make health insurance appear affordable is evidence of policy failure. Obamacare's constant price hikes are a direct result of the program's design. The law requires insurers to accept everyone, regardless of health status or history. And it bars payers from charging older people any more than three times what they charge younger people. Moreover, every Obamacare insurer is required to cover 10 essential health benefits—including maternal care and addiction treatment—regardless of whether people want or need them. These rules and regulations increase the cost of covering the average enrollee and push insurers to raise premiums each year. When the enhanced Biden-era subsidies expire at the end of this year, people could see their out-of-pocket premium payments jump by 75%, on average. That may cause many to consider less expensive, less comprehensive bronze or catastrophic coverage—and discover just how powerful a health savings account can be. HSAs allow beneficiaries to set aside pre-tax dollars to cover copays, deductibles, and other qualified medical expenses. The money in an HSA also grows tax-free. According to the Cato Institute, some 7.3 million Americans could become newly eligible for HSAs thanks to the One Big Beautiful Bill Act. In 2026, individuals will be able to contribute up to $4,400 a year to these accounts; families will be allowed to deposit up to $8,750. When people control their healthcare dollars, they have the opportunity to spend them as they—rather than their insurer—see fit. They can visit providers of their choosing and shop around for care that they believe delivers the best value. The One Big Beautiful Bill Act also permits people to use their HSA money to pay for direct primary care, wherein they pay a monthly or annual subscription fee for generally unlimited access to routine care from their doctor. It's possible that some people may be better off with a direct primary care subscription and a catastrophic plan than they would've been under the status quo. The consumerism encouraged by HSAs can reduce health spending. One study found that people with HSAs spent up to 7% less on health care than people without them—and up to 9% less at the pharmacy. Health costs have continued their upward march in the decade-plus since Obamacare became law. The One Big Beautiful Bill Act, with its modest expansion of HSAs, has taken some baby steps toward bringing those costs down. Exchange enrollees would be wise to take advantage.
Axios
2 hours ago
- Axios
Utah vaccine exemption rate rises to No. 2 in nation
Utah now has the nation's second highest rate of vaccine exemptions for kindergartners, as the state's share of fully immunized children continues to drop. Threat level: Utah's kindergarten vaccination rates have long fallen below the 95% needed for herd immunity against highly contagious illnesses — and kids are about to return to school amid a measles outbreak. As of fall 2024, just 88.6% of Utah kindergartners were up to date on their measles-mumps-rubella (MMR) vaccines, per new CDC data. Whooping cough was at 88.1%. Meanwhile, whooping cough is spreading in southwest Utah, health officials announced last week. What we're watching: Kindergarten vaccination rates in parts of Utah are dropping toward the 80% herd immunity threshold for polio, per the latest data from the state health department. More than 19% of kindergartners in southwest Utah were not fully vaccinated for polio, with nearly 15% in the central counties. The big picture: Anti-vax sentiments — once considered a liberal trend — gained ground on the political right amid hostility toward COVID prevention measures. A Gallup poll last year found that 69% of respondents viewed childhood vaccines as "extremely" or "very" important, down from 94% in 2001 — a drop researchers attributed to those who lean Republican. By the numbers: More than 10% of Utah kindergartners obtained immunization waivers last fall, up a full percent from the previous year. Only Idaho had a higher rate of exemptions, at 15.4%. The intrigue: Of the 10.3% of Utah kindergartners who sought exemptions, just 0.3% were for medical reasons. About 85% were for "personal" reasons, with "religion" accounting for another 12.5%. Catch up quick: A 2022 Axios analysis of Utah immunization data by ZIP code showed exemptions after 2020 largely spiked in politically conservative areas. Caveat: Vaccine waivers are far more common among online students, covering more than half of the state's nearly 1,500 online kindergartners. Of the 44,000 in-person kindergartners, 9% had exemptions, up from 7.9% a year before. Another 1% were out of compliance — neither vaccinated nor exempt. Flashback: Trump cut more than $30 million in Utah childhood immunization funding in April. Zoom in: Salt Lake County's exemption rate was the lowest of any local health district in the state at 5.5%.
